Rohit Sharma

Rohit Sharma

Auto-generated profile, based on publicly available information

Rohit Sharma

Department of Internal Medicine, Hamad Medical Corporation

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in IDCases
Verified
Journal Article
Open access
SSSundus Sardar
Sundus Sardar
RSRohit Sharma
Rohit Sharma
TATariq Yousef Mohammad Alyamani
Tariq Yousef Mohammad Alyamani
MAMohamed Aboukamar
Mohamed Aboukamar
The ongoing outbreak of COVID-19 poses an unprecedented global health challenge. With its variety of clinical manifestations including, but not limited to, fever, cough, diarrhea, vomiting, headache, myalgia and fatigue, it may be challenging to distinguish COVID-19 from a spectrum of diseases with similar presentations, such as malaria, especially in endemic areas. Risk of concomitant infections also remains a concern owing to overburdening of healthcare services and possible scarcity of resources. We present the first reported case of confirmed COVID and malaria co-infection. In this case, we emphasize the need for vigilance from frontline clinicians for timely diagnosis and appropriate clinical management of potential co-infections in the COVID era.

1 December 2020 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FAFateen Ata
Fateen Ata
ABAmmara Bint I Bilal
Ammara Bint I Bilal
SJSaad Javed
Saad Javed
HCHammad Shabir Chaudhry
Hammad Shabir Chaudhry
RSRohit Sharma
Rohit Sharma
AKAnand Bhaskaran Kartha
Anand Bhaskaran Kartha
Vitamin B12 (VitB12) deficiency rarely manifests with visual symptoms. Optic nerve damage in VitB12 deficiency is thought to be via degeneration. However, optic neuritis, though infrequent, has been reported secondary to VitB12 deficiency. We conducted a systematic review of all the reported cases of VitB12 deficiency with optic nerve involvement in Pubmed, Cochrane, and Google Scholar any date up to September 6, 2020. We have discussed the findings and compiled the available information on ophthalmological manifestations of VitB12 deficiency. We aim to provide a unified knowledge about the evidence related to types of optic neuropathies reported to date secondary to VitB12 deficiency. We also present a case of bilateral optic neuritis secondary to VitB12 deficiency. We present a 29-year-old previously healthy male with progressive, painful, bilateral, but asymmetric visual deterioration for forty-five days. A detailed history, examination, and laboratory workup were carried out. He was diagnosed as having optic neuritis secondary to VitB12 deficiency. He showed partial improvement with the replacement of VitB12. We suggest promptly identifying and replacing VitB12 in patients with optic neuritis with proven VitB12 deficiency to prevent permanent damage to the optic nerve. Patients with VitB12 deficiency should have a baseline fundoscopic exam to rule out subclinical optic nerve damage. Moreover, patients who present with visual disturbances should be screened for VitB12 deficiency, especially the vegan population.

3 April 2021 in Cureus
Verified
Journal Article
Open access
TMTrishala Menon
Trishala Menon
SGSaad Abdul Quddus Gandhi
Saad Abdul Quddus Gandhi
WTWarisha Tariq
Warisha Tariq
RSRohit Sharma
Rohit Sharma
SSSundus Sardar
Sundus Sardar
RSRomil Singh
Romil Singh
Coronavirus disease 19 (COVID-19) has affected over 180 countries, resulting in global mass death. It has been reported that patients with underlying disease are more likely to contract the disease and become critically ill. The impact of chronic kidney disease (CKD) on the severity of COVID-19 has been underlined in the literature. In this analysis, we have provided evidence of an association between CKD and COVID-19. We followed the PRISMA protocol and conducted a literature search using Google Scholar, EMBASE, PubMed, and Clinical trail.gov. The initial search yielded 2102 articles. We included 20 cohorts based on inclusion criteria reporting an association between CKD and COVID-19 after excluding irrelevant articles, including review articles and duplicates. We conducted pooled prevalence of CKD and meta-analysis to estimate the odds ratio (OR), 95% confidence interval (CI) using Cochrane RevMan (version 5.4, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration), and R programming language version 4.16-2 (University of Auckland, New Zealand). Our study involved 4350 patients from different countries, and 212 (4.9%) patients had CKD. Among 20 cohorts, 57.27% were male with a median age of 55.5 years. Eight hundred sixty-six patients developed severe COVID-19, and out of which, 39 (4.5%) were CKD patients. CKD patients had a significantly increased risk of severe disease as compared to non-CKD patients with a pooled OR of 2.15 (95% CI 1.16-4.01) (I2=41; p=0.02). Out of 443 COIVD-19 patients who died, 85 patients had CKD, with a prevalence of 19.18%. CKD patients had an increased risk of death as compared to non-CKD patients with a pooled OR of 5.58 (95% CI 3.27-9.54) (I2=0; p<0.00001). CKD is manifested as a common underlying disease in COVID-19 patients who had a worse prognosis, including mortality.

20 October 2020 in American Journal of Case Reports
Verified
Journal Article
Closed access
RSRohit Sharma
Rohit Sharma
SSSundus Sardar
Sundus Sardar
AAAbdullah Mohammad Arshad
Abdullah Mohammad Arshad
FAFateen Ata
Fateen Ata
SZSabeen Zara
Sabeen Zara
WMWaqar Munir
Waqar Munir
A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 - Article abstract #927154

1 May 2005 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Open access
PDF file
RRRajesh RamachandranNair
Rajesh RamachandranNair
RSRohit Sharma
Rohit Sharma
SWShelly Weiss
Shelly Weiss
HOHiroshi Otsubo
Hiroshi Otsubo
MCMiguel A. Cortez
Miguel A. Cortez
Objective: This study was designed to determine the prevalence of rhythmic coma patterns in comatose children and to ascertain the prognostic significance of reactive rhythmic coma patterns. Methods: We retrospectively analyzed and classified electroencephalogram (EEGs) in comatose children between two months and 18 years of age during the period 1996 - 2003 according to modified Young's classification. Outcome at one-year was scored according to the Paediatric Cerebral and Overall Performance Category Scale. Outcomes were compared using Fisher's exact test and Mann-Whitney test. Results: Analysis of 63 electroencephalogram (EEG) records in 38 patients showed rhythmic patterns in 19 records (30.2%; 9 alpha, 4 spindle, 4 theta and 2 beta coma patterns, total number of children = 14). Aetiology and outcome of alpha coma patterns and other rhythmic coma patterns were similar. In five children, one type of rhythmic pattern changed to another. Records with reactive rhythmic coma 66.7% (6/9), were associated with favourable outcome. Sixty percent of the records (6/10 records in seven children) with non-reactive pattern were associated with unfavourable outcome. This clinically significant difference did not reach statistical significance (lower Paediatric Cerebral and Overall Performance Category Scale score p= 0.14; favourable outcome p=0.19). Conclusion: Rhythmic coma patterns in comatose children are not uncommon. Aetiology, reactivity and outcome of individual patterns are similar and thus make the rhythmic coma patterns distinct EEG signatures in comatose children. There was a clinically significant better outcome with reactive rhythmic coma patterns. RÉSUMÉ: Objectif: Cette étude a été conçue pour déterminer la prévalence de l’activité rythmique chez les enfants comateux et pour évaluer la valeur pronostique de l’activité rythmique réactive chez ces enfants. Méthodes: Nous avons analysé et classifié de façon rétrospective les ÉEG d’enfants comateux âgés de 2 mois à 18 ans entre 1996 et 2003 selon la classification modifiée de Young. L’issue à 1 an était évaluée selon la Paediatric Cerebral and Overall Performance Category Scale (PCOPCS). Les résultats ont été analysés au moyen du test de Fisher et du test de Mann-Whitney. Résultats: L’analyse de 63 ÉEGs chez 38 patients a révélé la présence d’activité rythmique dans 19 enregistrements (30,2% dont la présence de rythme alpha chez 9, de fuseaux chez 4, de rythme thêta chez 4 et de rythme bêta chez 2, chez 14 enfants au total). L’étiologie et l’issue du coma étaient similaires quel que soit le rythme observé. Chez 5 enfants, un type d’activité rythmique a changé pour un autre. Chez 66,7% (6/9) des enregistrements de tracé de coma réactif l’issue a été favorable et chez 60% (6/10 enregistrements faits chez sept enfants) ayant un tracé de coma non réactif l’issue a été défavorable. Cette différence importante au point de vue clinique n’atteignait pas le seuil de la significativité statistique (score PCOPCS plus bas p= 0,14 ; issue favorable p = 0,19). Conclusion: On observe fréquemment différents types d’activité rythmique chez les enfants comateux. L’étiologie, la réactivité et l’issue de chaque type de rythme sont similaires, ce qui confère à ces rythmes une signification ÉEG distincte chez les enfants comateux. L’issue était bien meilleure au point de vue clinique pour les rythmes de coma réactif.

8 February 2021
Verified
Preprint
Open access
PDF file
RSRohit Sharma
Rohit Sharma
SSSundus Sardar
Sundus Sardar
PIPhool Iqbal
Phool Iqbal
AAAyisha Ameen
Ayisha Ameen
GAGholam A Adeli
Gholam A Adeli
AEAbdel-Naser Elzouki
Abdel-Naser Elzouki
COVID-19-associated acute motor axonal neuropathy, a variant of Guillain-Barré Syndrome: Expanding the neurological manifestations of SARS-CoV-2